Company Performance Metrics
- Jennifer Heymont: Associate Director, Scientific InformaticsPast Role: Eisai US, Senior Data Scientist
- Ricardo Sáinz Fuertes: Global Director of Digital Health SolutionsPast Role: Eisai US, Medical Director of Epilepsy for Europe, Middle East, Africa, Russia and Australia
Eisai Inc. (pronounced ā-zī) is a U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd, a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Established in 1995, Eisai Inc. began marketing its first product in the United States in 1997 and has rapidly grown to become an
integrated pharmaceutical business.
Headquartered in Woodcliff Lake, New Jersey, they are dedicated to a tradition of genuine concern for people and are driven by the desire to help meet the diverse health care needs of patients and their families and caregivers. They are an agile, entrepreneurial organization managed by experienced leadership, backed by the strength, stability and historical successes of Eisai Co., Ltd., which has a strong and lasting commitment to the U.S. market.
Their heritage and mission have earned us recognition as an innovative, efficient, solution-oriented pharmaceutical company - a company that effectively works with healthcare professionals, hospitals and managed care organizations to develop and market specialty products that help address unmet needs. Their ability to forge strong alliances gives us a competitive edge.
In the United States, their rapid growth and strong performance result from putting patients and their families first when making decisions and from empowering the people who manage their operations. Eisai employees personify their values of integrity, respect, professionalism, quality and teamwork.
